GLOW Skin Peptide

Description

GLOW is a research-grade skin peptide blend available in Canada, combining three well-studied bioactive peptides — BPC-157, GHK-Cu (Copper Tripeptide-1), and TB500 (Thymosin Beta-4) — in a single lyophilized powder

What Is the GLOW Skin Peptide Blend?

GLOW is a multi-peptide research formulation combining three well-studied bioactive peptides — BPC-157, GHK-Cu (Copper Tripeptide-1), and TB500 (Thymosin Beta-4) — in a single lyophilized powder. Researchers investigating skin health, cellular regeneration, and collagen dynamics commonly examine this blend for its potential synergistic activity across multiple signalling pathways involved in dermal repair and antioxidant response.

Available in Canada for research use only, GLOW is supplied as a sterile lyophilized powder with a Certificate of Analysis confirming peptide identity and purity.

Key Ingredients & Research Overview

BPC-157 — Body Protection Compound-157 (CAS 137525-51-0)

BPC-157 is a 15-amino-acid peptide derived from a gastric protective protein sequence. In preclinical research models, BPC-157 has been studied for its potential role in:

• Angiogenesis signalling — upregulation of VEGFR2 pathways to support new blood vessel formation in tissue models
• Tissue repair acceleration — examined in soft tissue, tendon, and mucosal healing studies
• Anti-inflammatory activity — investigated for modulating inflammatory cytokine expression in wound models
• Skin barrier support — explored for its potential influence on epithelial cell migration and re-epithelialization

GHK-Cu — Copper Tripeptide-1 (CAS 49557-75-7)

GHK-Cu is a naturally occurring copper-binding peptide found in human plasma, saliva, and urine. Concentrations decline with age, making it a focus in dermal and regenerative research. Research areas include:

• Collagen and elastin synthesis — GHK-Cu has been studied for its influence on fibroblast activity and extracellular matrix remodelling
• Skin elasticity and firmness — frequently examined as a marker in cosmetic peptide research
• Antioxidant gene expression — shown in vitro to upregulate antioxidant enzymes including superoxide dismutase
• Wound contraction — studied for its role in wound healing kinetics and skin remodelling

GHK-Cu is the primary skin-targeting peptide in the GLOW blend and is among the most extensively researched cosmetic peptides globally.

TB500 — Thymosin Beta-4 Fragment (CAS 77591-33-4)

TB500 is a synthetic analogue of Thymosin Beta-4, an endogenous peptide with roles in actin regulation and cellular motility. In skin and tissue research, TB500 is studied for:

• Cell migration and recruitment — TB500 promotes actin polymerization, supporting keratinocyte and endothelial cell migration in wound models
• Tissue remodelling — investigated for its involvement in extracellular matrix organization
• Inflammation modulation — examined for its potential to reduce pro-inflammatory markers in tissue repair studies
• Vascular integration — studied alongside angiogenic factors in regeneration research

Why Researchers Choose the GLOW Blend

The rationale for combining these three peptides is their complementary, non-overlapping mechanisms of action:

• BPC-157 initiates and supports early-phase vascular and epithelial repair
• GHK-Cu targets collagen deposition and antioxidant upregulation in the dermal layer
• TB500 supports cellular migration and extracellular matrix organization in later repair phases

Together, this creates a multi-pathway research model applicable to skin regeneration, wound healing, and anti-aging dermal studies — making GLOW a widely selected formulation among Canadian peptide researchers.

Product Specifications

Frequently Asked Questions

What is the GLOW peptide blend used for in research?

GLOW is studied as a multi-peptide formulation for skin and tissue regeneration. Researchers examine its combined effects on collagen synthesis, cellular repair, angiogenesis, and antioxidant activity in dermal tissue models.

What peptides are in GLOW?

GLOW contains three peptides: BPC-157 (Body Protection Compound-157), GHK-Cu (Copper Tripeptide-1), and TB500 (Thymosin Beta-4 fragment), all in lyophilized powder form.

Is GLOW available in Canada?

Yes. GLOW Skin Peptide Blend is available for purchase in Canada for research and ships Canada-wide. Free express shipping applies on orders over $300.

Is this product for human use?

No. GLOW is intended strictly for laboratory research use only. It has not been evaluated or approved by Health Canada for human therapeutic use.

What is the difference between GLOW and individual peptides like BPC-157 or GHK-Cu?

Individual peptides target specific pathways. The GLOW blend combines BPC-157, GHK-Cu, and TB500 to create a multi-pathway research model, allowing researchers to study complementary mechanisms simultaneously across vascular, collagen, and cellular repair processes.

Does GLOW come with a Certificate of Analysis?

Yes. All Metalink Peptides products are supplied with a Certificate of Analysis confirming peptide identity and purity.

For research use only. This product has not been evaluated or approved by Health Canada. Not intended for human consumption or therapeutic use.